Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma
Publication
, Journal Article
Chen, W; Farchoukh, L; Seigh, L; Hartman, DJ; Pai, RK
Published in: Histopathology
November 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Histopathology
DOI
EISSN
1365-2559
ISSN
0309-0167
Publication Date
November 2021
Volume
79
Issue
5
Start / End Page
826 / 835
Publisher
Wiley
Related Subject Headings
- Pathology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, W., Farchoukh, L., Seigh, L., Hartman, D. J., & Pai, R. K. (2021). Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma. Histopathology, 79(5), 826–835. https://doi.org/10.1111/his.14430
Chen, Wei, Lama Farchoukh, Lindsey Seigh, Douglas J. Hartman, and Reetesh K. Pai. “Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma.” Histopathology 79, no. 5 (November 2021): 826–35. https://doi.org/10.1111/his.14430.
Chen W, Farchoukh L, Seigh L, Hartman DJ, Pai RK. Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma. Histopathology. 2021 Nov;79(5):826–35.
Chen, Wei, et al. “Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma.” Histopathology, vol. 79, no. 5, Wiley, Nov. 2021, pp. 826–35. Crossref, doi:10.1111/his.14430.
Chen W, Farchoukh L, Seigh L, Hartman DJ, Pai RK. Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma. Histopathology. Wiley; 2021 Nov;79(5):826–835.
Published In
Histopathology
DOI
EISSN
1365-2559
ISSN
0309-0167
Publication Date
November 2021
Volume
79
Issue
5
Start / End Page
826 / 835
Publisher
Wiley
Related Subject Headings
- Pathology
- 1103 Clinical Sciences